Cotización Conduit Pharmaceuticals - CDT

Herramientas de nivel profesional para inversores individuales.

Premium

Último Precio

0.1341

Postura de Compra

0.1341

Postura de Venta

0.1362

Volume Operado de la Acción

861,110

0.127 Rango del Día 0.137

0.1126 Rango de 52 semanas 12.89

Capitalización de Mercado [m]

12.874M

Precio Anterior

0.1352

Precio de Apertura

0.137

Hora

100

0.1341

Última hora de negociación

11:13:25

Volumen financiero

US$ 113,815

Precio Promedio Ponderado

0.132172

Volumen promedio (3 m)

13,948,847

Acciones en circulación

96,004,699

Rendimiento del Dividendo

Ratio Precio/Utilidad

-267.04

Beneficio por acción (BPA)

-0.06

turnover

Beneficio neto

-6.06M

Conduit Pharmaceuticals, Inc. is a disease agnostic life science company. The Company is engaged in the development and commercialization of clinical assets to address the unmet medical needs of patients. The Company¿s licensed clinical assets are focused on idiopathic male infertility and autoimmun... Conduit Pharmaceuticals, Inc. is a disease agnostic life science company. The Company is engaged in the development and commercialization of clinical assets to address the unmet medical needs of patients. The Company¿s licensed clinical assets are focused on idiopathic male infertility and autoimmune diseases or immunodeficient conditions like uveitis, preterm labor, renal transplant rejection and Hashimoto¿s Thyroiditis. The Company¿s asset pipeline includes AZD1656 (a Glucokinase Activator), and AZD5904 (a Myeloperoxidase Inhibitor). AZD1656 is a glucokinase activator used in diabetes mellitus. It is used as a treatment option for Hashimoto¿s Thyroiditis (HT) and Graves¿ disease, including investigating any negative side effects of the use of AZD1656 as compared with treatment options for Hashimoto¿s Thyroiditis and Graves¿ disease. AZD5904 includes a potent, irreversible inhibitor of human myeloperoxidase (MPO), that has the potential to treat Idiopathic Male Infertility (IMI). Mostrar más

Sector

Pharmaceutical Preparations

Industria

Pharmaceutical Preparations

Sitio web

www.conduitpharma.com

Sede

Wilmington, Delaware, USA

Fundado

Conduit Pharmaceuticals Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker CDT. The last closing price for Conduit Pharmaceuticals was US$0.14. Over the last year, Conduit Pharmaceuticals shares have traded in a share price range of US$ 0.1126 to US$ 12.89.

Conduit Pharmaceuticals currently has 96,004,699 shares in issue. The market capitalisation of Conduit Pharmaceuticals is US$12.98 million. Conduit Pharmaceuticals has a price to earnings ratio (PE ratio) of -267.04.

Conduit Pharmaceuticals to Present at the H.C. Wainwright 26th Annual Global Investment Conference

SAN DIEGO and LONDON, Aug. 28, 2024 (GLOBE NEWSWIRE) -- Conduit Pharmaceuticals Inc. (Nasdaq: CDT) (“Conduit” or the “Company”), today announced it will be participating in the H.C. Wainwright...

Conduit Pharmaceuticals Selects Initial Indications for Lead Clinical Candidate Targeting Autoimmune Disorders

Conduit Pharmaceuticals announces plans to initiate Phase 2a trials in both systemic lupus erythematosus and ANCA-associated vasculitis for its lead clinical candidate, AZD1656AZD1656, a HK-4...

Conduit Pharmaceuticals Enters into Exclusive License Agreement with AstraZeneca for Multiple Assets to Advance Potential First-in-Class Treatments

Conduit Pharmaceuticals enters into exclusive license agreement with AstraZeneca for HK-4 Glucokinase activators AZD1656 and AZD5658 targeting autoimmune indications and myeloperoxidase inhibitor...

Período †	Variación(Ptos)	Variación %	Apertura	Precio Máximo	Precio Mínimo	Avg. Vol. diario	Precio Promedio Ponderado
1	-0.0058	-4.14581844174	0.1399	0.143	0.127	1664686	0.13521558	CS
4	-0.0243	-15.3409090909	0.1584	0.178	0.1126	4278000	0.13396138	CS
12	-0.9359	-87.4672897196	1.07	1.2299	0.1126	13948847	0.18624998	CS
26	-2.9759	-95.6881028939	3.11	3.92	0.1126	6393699	0.19461863	CS
52	-12.4659	-98.9357142857	12.6	12.89	0.1126	3411111	0.30279137	CS
156	-12.4659	-98.9357142857	12.6	12.89	0.1126	3411111	0.30279137	CS
260	-12.4659	-98.9357142857	12.6	12.89	0.1126	3411111	0.30279137	CS

Volumen
% Mayores Alzas
% Mayores Bajas

Símbolo	Precio	Vol.
GSIWGarden Stage Ltd	US$ 5.9001 (159.92%)	34.33M
ZEOZeo Energy Corporation	US$ 2.7502 (141.25%)	52.67M
TBIOTelesis Bio Inc	US$ 2.7127 (99.46%)	48.61M
XCURExicure Inc	US$ 3.896 (70.13%)	14.9M
EWTXEdgewise Therapeutics Inc	US$ 29.575 (55.09%)	7.87M
HAOHaoxi Health Technology Ltd	US$ 0.769699 (-74.34%)	6.31M
GDHGGolden Heaven Group Holdings Ltd	US$ 2.585 (-38.01%)	373.21k
HOVRNew Horizon Aircraft Ltd	US$ 0.478 (-35.49%)	1.59M
XCHXCHG Ltd	US$ 12.40 (-32.50%)	751.37k
BLMZBloomZ Inc	US$ 0.9248 (-32.50%)	385.86k
NVDANVIDIA Corporation	US$ 119.1401 (5.09%)	134.5M
SQQQProShares UltraPro Short QQQ	US$ 7.6999 (-8.33%)	121.06M
FRGTFreight Technologies Inc	US$ 0.131396 (6.05%)	68.33M
MAXNMaxeon Solar Technologies Ltd	US$ 0.1038 (14.19%)	66.91M
TSLATesla Inc	US$ 242.285 (6.64%)	53.91M